crizanlizumab
novartis
['crizanlizumab']
dr. andersen pr sents int rim results of spartan trial of crizanlizumab for priapism in scd 12 years and older 50% median reduction in events #scd #ash2022 
Adult and pediatric hematologist, sickle cell provider and advocate